期刊
BRITISH JOURNAL OF PSYCHIATRY
卷 221, 期 5, 页码 676-682出版社
CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.2022.110
关键词
Post-traumatic stress disorder; suicide; risk assessment; quantitative research; military psychiatry
类别
资金
- National Institutes of Mental Health [R01MH121397]
This is the first population-based study to simultaneously consider PTSD diagnosis and symptom severity, finding that any level of PTSD symptoms above the minimum threshold for symptomatic remission is associated with an increased suicide mortality rate. Improving PTSD symptoms can reduce the risk of suicide mortality, but achieving symptomatic remission is necessary to attain this benefit.
Background There is mixed evidence regarding the direction of a potential association between post-traumatic stress disorder (PTSD) and suicide mortality. Aims This is the first population-based study to account for both PTSD diagnosis and PTSD symptom severity simultaneously in the examination of suicide mortality. Method Retrospective study that included all US Department of Veterans Affairs (VA) patients with a PTSD diagnosis and at least one symptom severity assessment using the PTSD Checklist (PCL) between 1 October 1999 and 31 December 2018 (n = 754 197). We performed multivariable proportional hazards regression models using exposure groups defined by level of PTSD symptom severity to estimate suicide mortality rates. For patients with multiple PCL scores, we performed additional models using exposure groups defined by level of change in PTSD symptom severity. We assessed suicide mortality using the VA/Department of Defense Mortality Data Repository. Results Any level of PTSD symptoms above the minimum threshold for symptomatic remission (i.e. PCL score >18) was associated with double the suicide mortality rate at 1 month after assessment. This relationship decreased over time but patients with moderate to high symptoms continued to have elevated suicide rates. Worsening PTSD symptoms were associated with a 25% higher long-term suicide mortality rate. Among patients with improved PTSD symptoms, those with symptomatic remission had a substantial and sustained reduction in the suicide rate compared with those without symptomatic remission (HR = 0.56; 95% CI 0.37-0.88). Conclusions Ameliorating PTSD can reduce risk of suicide mortality, but patients must achieve symptomatic remission to attain this benefit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据